The clinical phenotype of infants with homozygous deletion or homozygous loss-of function mutations of the TASP1 gene includes developmental delay, anomalies related to skeletal and organ systems, recurrent respiratory infections, anemia and a lack of early erythroid precursors combined with an impaired megakaryopoiesis. Here, TASP1 is linked to respiratory tract infectious disorder.